Table 4.
Correlation between study markers and patients parameters in cirrhotic and HCC groups
| Parameters | Cirrhotic patients | HCC patients | ||
|---|---|---|---|---|
| R | p | R | P | |
| DKK1 | ||||
| ALT | 0.218 | 0.355 | 0.170 | 0.225 |
| AST | 0.181 | 0.445 | 0.305 | 0.028 |
| Total bilirubin | 0.432 | 0.065 | -0.017 | 0.905 |
| Albumin | -0.281 | 0.244 | -0.346 | 0.014 |
| Hb concentration (g/dl) |
0.045 | 0.849 | -0.176 | 0.209 |
| WBCs count (x 103/μl) |
0.487 | 0.034 | -0.004 | 0.976 |
| Platelets count (x 103/μl) |
0.257 | 0.273 | -0.086 | 0.539 |
| AREG | ||||
| ALT | 0.226 | 0.353 | 0.058 | 0.675 |
| AST | 0.198 | 0.417 | 0.114 | 0.416 |
| Total bilirubin | 0.165 | 0.513 | -0.104 | 0.456 |
| Albumin | -0.231 | 0.357 | -0.076 | 0.596 |
| Hb concentration (g/dl) |
0.003 | 0.991 | -0.140 | 0.313 |
| WBCs count (x 103/μl) |
0.200 | 0.411 | -0.273 | 0.046 |
| Platelets count (x 103/μl) |
-0.137 | 0.577 | -0.145 | 0.295 |
r= Correlation coefficient, HCC: Hepatocellular carcinoma, DKK1: Dickkopf-1, AREG: Amphiregulin, ALT: Alanine aminotransferase, AST: Aspartate aminotransferase, Hb: Hemoglobin, WBCs: white blood cells